European Healthtech startup funding raised during Q4 2016.
In Q4 2016, 103 European Healthtech companies raised a combined €520M across 107 funding rounds, down 21.7% versus Q4 2015. Ireland led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Carrick Therapeutics | Series A | Oct 2016 | €86M |
| NaPopravku | Early VC | Dec 2016 | €46M |
| Genomics Medicine Ireland | Series A | Oct 2016 | €36M |
| Genfit | Growth/Late |
8 exits · €42M disclosed.
| Genesort | Acquisition | Dec 2016 | €21M |
| Luck Genome | Acquisition | Oct 2016 | €11M |
| Linkcare | Acquisition | Oct 2016 | €5.0M |
| dariohealth | IPO | Nov 2016 | €4.6M |
| Oct 2016 |
| €34M |
| BONESUPPORT | Growth/Late | Oct 2016 | €33M |
| OxThera | Other | Nov 2016 | €32M |
| NBE-Therapeutics | Series B | Nov 2016 | €19M |
| Corwave | Series B | Nov 2016 | €16M |
| Physidia | Growth/Late | Oct 2016 | €15M |
| Neuravi | Debt | Nov 2016 | €15M |
| Uromems | Series A | Nov 2016 | €12M |
| Univercells | Grant | Dec 2016 | €12M |
| Fortimedix | Series A | Oct 2016 | €11M |
| QGel | Growth/Late | Dec 2016 | €11M |
| Ava | Series A | Nov 2016 | €8.8M |
